Negative regulation of post-translational protein modification

pathway activity — cross-omics
GO:1901874Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of post-translational protein modification pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PLEKHH1, LIMK1, and IFI16, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of post-translational protein modification activity versus PLEKHH1 in LSCC (Pearson r = -0.25).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCPLEKHH1 →-0.460-0.101.002<.00135
CCRCCLIMK1 →+0.757+0.233<.001<.00135
UCECIFI16 →+0.685+0.139<.001.00434
GBMADAMTS17 →-0.539-0.105<.001<.00134
LSCCCTSC →+0.610+0.112<.001.00134
LSCCPAIP2B →-0.463-0.077<.001.00534
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1901874 vs PLEKHH1 — LSCC

Per-sample scatter of Negative regulation of post-translational protein modification activity vs PLEKHH1 in LSCC.

Explore this scatter interactively →

Exploration